Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aavis Pharmaceuticals is a USFDA-approved specialty pharmaceutical company focused on the contract development and manufacturing of complex oral solid generics. The company has more than 12 products commercially launched or filed with the USFDA. It specializes in advanced formulation technologies such as immediate/controlled/chrono/pulsatile/delayed-release systems for oral solids. In partnership with Jubilant Pharma Ltd., it has commercialized hydroxychloroquine sulfate tablets in the U.S. R&D efforts are ongoing to enhance existing formulations and develop new drug molecules for improved patient compliance.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aavis Pharmaceuticals.